发明名称 CROSSLINKED HYALURONIC ACID COMPOSITIONS FOR TISSUE AUGMENTATION
摘要 A hyaluronic acid (HA) composition includes crosslinked, water-insoluble, hydrated HA gel particles. The HA includes crosslinks represented by the following structural formula: HA.prime.-U-R2-U- HA.prime.. The variables are defined herein. A method of augmenting tissue in a subject includes insertin g a needle into a subject at a location in the subject that is in need of tiss ue augmentation, wherein the needle is coupled to a syringe loaded with the HA composition, and applying force to the syringe, to deliver the HA compositio n into the subject. A method of preparing the HA composition, includes forming water-insoluble, dehydrated crosslinked HA particles, separating the water- insoluble, dehydrated particles by average diameter, selecting a subset of particles by average diameter, and hydrating the subset of dehydrated particles with a physiologically compatible aqueous solution. Another method of preparing the crosslinked HA composition includes crosslinking a precurso r of the crosslinked HA with a biscarbodiimide in the presence of a pH buffer and dehydrating the crosslinked HA.Also included is a method of augmenting tissue in a subject that is in need of tissue augmentation. A method of stabilizing crosslinked HA includes hydrating water-insoluble, dehydrated crosslinked HA with a physiologically compatible aqueous solution that includes a local anesthetic, wherein the value of storage modulus G' for the stabilized composition is at least about 110% of the value of G' for a non- stabilized composition. Also included is the stabilized HA composition.</SDO AB>
申请公布号 CA2551121(A1) 申请公布日期 2005.07.28
申请号 CA20032551121 申请日期 2003.12.23
申请人 ANIKA THERAPEUTICS, INC. 发明人 SHERWOOD, CHARLES H.;BUI, KYLE;GOODING, TAMARA B.;SADOZAI, KHALID K.
分类号 A61L27/52;A61K9/00;A61K31/24;A61K39/395;A61K47/36;A61K48/00;A61L27/54;A61L27/58 主分类号 A61L27/52
代理机构 代理人
主权项
地址